Eterna Therapeutics
ERNA
#10747
Rank
A$10.53 M
Marketcap
A$9.03
Share price
-6.48%
Change (1 day)
200.09%
Change (1 year)

EPS for Eterna Therapeutics (ERNA)

EPS in 2025 (TTM): A-$111.33

According to Eterna Therapeutics's latest financial reports the company's current EPS (TTM) is A-$110.52. In 2022 the company made an earnings per share (EPS) of A-$181.32 an increase over its 2021 EPS that were of A-$1,198.

EPS history for Eterna Therapeutics from 2021 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$111.33
2022A-$181.32-84.86%
2021A-$1,198

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Sanofi
SNY
A$3.69-103.34%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
A-$3.07-97.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Omeros Corporation
OMER
A-$2.91-97.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
A-$0.19-99.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Genetic Technologies
GENE
N/AN/A๐Ÿ‡ฆ๐Ÿ‡บ Australia
Teva Pharmaceutical Industries
TEVA
A$1.97-101.79%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Bio-Techne
TECH
A$1.02-100.93%๐Ÿ‡บ๐Ÿ‡ธ USA